Biogen, Inc. (BIIB)
168.57
-0.74
(-0.44%)
USD |
NASDAQ |
Jan 15, 16:00
168.50
-0.07
(-0.04%)
After-Hours: 20:00
Biogen SG&A Expense (TTM): 2.431B for Sept. 30, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Eli Lilly & Co. | 10.39B |
| Stoke Therapeutics, Inc. | 58.79M |
| AbbVie, Inc. | 13.97B |
| Alnylam Pharmaceuticals, Inc. | 1.181B |
| Insmed, Inc. | 631.20M |